Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
In the September 14, 2015, Federal Register, FDA announced the fee rates for fiscal year 2016 associated with using a tropical disease priority review voucher ($2.7m).
United StatesFood, Drugs, Healthcare, Life Sciences
In the September 14, 2015, Federal Register, FDA
announced the fee rates for fiscal year 2016 associated with using
a tropical disease priority review voucher ($2.7m). The fee is
determined each fiscal year based on an analysis of the prior
year's data regarding the difference between the average cost
incurred by FDA in the review of a human drug application subject
to priority review and the average cost incurred in the review of
an application not subject to priority review.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
